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Abstract
Photosensitive retinal ganglion cells (pRGCs) respond to light from birth and represent the earliest known light detection
system to develop in the mouse retina. A number of morphologically and functionally distinct subtypes of pRGCs have been
described in the adult retina, and have been linked to different physiological roles. We have previously identified two
distinct isoforms of mouse melanopsin, Opn4L and Opn4S, which are generated by alternate splicing of the Opn4 locus.
These isoforms are differentially expressed in pRGC subtypes of the adult mouse retina, with both Opn4L and Opn4S
detected in M1 type pRGCs, and only Opn4L detected in M2 type pRGCs. Here we investigate the developmental expression
of Opn4L and Opn4S and show a differential profile of expression during postnatal development. Opn4S mRNA is detected
at relatively constant levels throughout postnatal development, with levels of Opn4S protein showing a marked increase
between P0 and P3, and then increasing progressively over time until adult levels are reached by P10. By contrast, levels of
Opn4L mRNA and protein are low at birth and show a marked increase at P14 and P30 compared to earlier time points. We
suggest that these differing profiles of expression are associated with the functional maturation of M1 and M2 subtypes of
pRGCs. Based upon our data, Opn4S expressing M1 type pRGCs mature first and are the dominant pRGC subtype in the
neonate retina, whereas increased expression of Opn4L and the maturation of M2 type pRGCs occurs later, between P10
and P14, at a similar time to the maturation of rod and cone photoreceptors. We suggest that the distinct functions
associated with these cell types will develop at different times during postnatal development.
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Introduction
Melanopsin expressing retinal ganglion cells are photosensitive
(pRGCs) and represent a third class of ocular photoreceptor
involved in the regulation of irradiance detection and non-image
forming responses to light, including pupil constriction, circadian
entrainment and the regulation of sleep [1,2]. In mice, pRGCs are
photosensitive from birth and are the earliest light detection system
to develop in the mammalian retina [3,4,5]. However, it is now
clear that multiple subtypes of pRGCs exist in the adult
mammalian retina [6]. These pRGC subtypes are characterised
based primarily on levels of melanopsin expression and the
stratification of their dendrites within specific sub laminae of the
inner plexiform layer (IPL). M1 type pRGCs express higher levels
of melanopsin and have dendrites located in the OFF layer of the
IPL, whereas M2 type pRGCs have lower levels of melanopsin
expression and dendrites that stratify in the ON sub lamina of the
IPL [7,8,9,10,11,12]. A third type of pRGC, termed M3 type
pRGCs, has also been described with dendrites in both the OFF
and ON layers of the IPL [7,10,12,13], but these cells are rare and
may represent an anomalous class of pRGC [10,13]. Most recently
two further pRGC subtypes have been identified; M4 and M5 type
pRGCs, that are broadly similar in morphology to M2 type
pRGCs with dendrites stratifying in the ON layer of the IPL.
However, levels of melanopsin expression are low in these cells
and they are not easily identified using a highly sensitive
melanopsin antibody [8,10].
In addition to their distinctive morphology and retinal
connections there is growing evidence that functional differences
exist between the pRGC subtypes, including membrane properties
and resting membrane potentials, as well as levels of photosensi-
tivity and the kinetics of photoresponses [8,14,15]. Most notable is
the observation that the pRGC subtypes innervate specific retino-
recipient brain areas [11,16,17] and would seem to mediate
different physiological responses to light [18]. Collectively these
findings show that the pRGC subtypes are morphologically,
anatomically and functionally distinct cell types, although their
specific physiological functions remains to be fully determined. As
the different retinal cell layers are not fully formed at birth and
stratification of ganglion cell dendrites occurs postnatally [19], it is
difficult to classify pRGCs that appear early in development as
either M1 or M2 type pRGCs based upon morphology and
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the development of these functionally different cell types.
We have shown previously that two distinct isoforms of mouse
melanopsin, Opn4L and Opn4S, are generated by alternative
splicing of the murine Opn4 gene [20]. These two isoforms of
melanopsin differ only in their C-terminal regions and are
differentially expressed in M1 and M2 type pRGCs in the adult
mouse retina. M1 cells express both Opn4L and Opn4S whereas
only Opn4L can be detected in M2 type cells. To date, the
developmental expression of Opn4L and Opn4S has not been
investigated, and as such it is not clear whether this differential
pattern of expression is present in pRGCs from birth or occurs
postnatally as specific pRGC subtypes develop. In this study we
use qPCR and immunohistochemistry to investigate the expression
of Opn4S and Opn4L isoforms during postnatal development of
the mouse retina. Our results show a different profile of expression
for Opn4L and Opn4S during development, and we propose that
these differences are linked to the differential maturation of M1
and M2 subtypes of pRGCs.
Methods
Ethics Statement
All procedures were conducted in accordance with the Animals
(Scientific Procedures) Act 1986 (PPL 70/6382 and 30/2812) and
the University of Oxford Policy on the Use of Animals in Scientific
Research and approved by the Home Office (UK) Animals
Scientific Procedures Department (ASPD). All procedures were
performed in a designated establishment. Animals were sacrificed
by Schedule 1 methods. Retinal tissue from neonates (,P10) was
collected following a non-schedule 1 method (decapitation), under
authority of the relevant project licence.
Animals
Wild type mice (C3H/He; not carrying rd mutation) [21] were
housed under a 12:12 LD cycle with food and water ad libitum. For
analysis of developmental time points, animals (P0, P3, P5, P10,
P14 and P30, n=6 per time point) were sacrificed at ZT8 and eyes
were removed and processed for immunohistochemistry or retina
isolated and stored at 280uC for PCR analysis. For analysis of
daily rhythms in melanopsin mRNA expression, C3H/He mice
(P30–90) were sacrificed at ZT3, ZT8, ZT13, ZT18 and ZT23,
n=4 per time point. ZT0=lights on, ZT12=lights off.
qPCR
Tissue was homogenised in TRIzol Reagent (Life Technologies)
and total RNA isolated using RNeasy spin columns (Qiagen) and
DNase treatment (Qiagen). RNA content was quantified using a
nanandrop spectrophotometer (Thermo), and for each sample
0.5 mg of total RNA was reverse transcribed using SuperScript III
with oligo(dT)20 primers (Life Technologies). Quantitative PCR
was performed using Sybr Green I mastermix on a StepOne
thermal cycler (Applied Biosystems) as described previously [20].
Relative quantification of transcript levels was performed with a
comparative CT approach with levels of target gene expression
normalised to the geometric mean expression of three house-
keeping genes, Gapdh, Psmb2 and Arbp [22]. Primer sequences are
shown in Table 1.
Antibodies: Polyclonal antibodies recognising the different C-
terminal regions of murine Opn4L (raised in rabbit) and Opn4S
(raised in goat) were raised against 15 amino acid synthetic
peptides conjugated to KLH by Harlan UK, according to their
standard procedures (Opn4S: SPQTKGHLPSLDLGM; Opn4L:
PHPHTSQFPLAFLED) [20]. Both antibodies were affinity
purified prior to use using standard techniques (Thiolink gel kit,
Severn Biotech Ltd). A rabbit polyclonal antibody recognising
the N-terminus of murine Opn4 common to both Opn4L and
Opn4S was obtained commercially (UF006; Advanced Targeting
Systems) [23].
Validation of antibodies
All three melanopsin antibodies used in this study have been
characterised previously, and label a subset of cells in the ganglion
cell layer of the retina consistent with pRGCs in wildtype but not
Opn4
2/2 mice [8,10,20,23]. The Opn4L and Opn4S antibodies
recognise only their respective isoforms [20], and the UF006
antibody recognises both Opn4L and Opn4S (Figure S1).
Immunohistochemistry
Whole eyes (n=4 animals for each time point) were removed,
punctured with a fine gauge needle and placed in 4%
paraformaldehyde (PFA) (Thermo Scientific) in PBS at 4uC for
16 h. Eyes were then cryoprotected in 30% sucrose in PBS at 4uC
for 48 h, embedded in OCT medium (Sakura Finetek) and stored
at 280uC. 18 mm tissue sections were cut at 223uC using a Leica
CM1850 cryostat (Leica Microsystems) and collected on poly-L-
lysine coated slides (Thermo Scientific). For immunohistochemis-
try, sections were permeabilised in PBS with 0.2% Triton-X for
20 mins at RT then blocked in PBS with 10% donkey serum for
1 h at RT. N-terminal UF006 (1:2,500), Opn4S (1:100) and
Opn4L (1:50) primary antibodies were incubated for 24–72 h at
4uC. Donkey anit-rabbit Alexa555 and donkey anti-goat Alexa488
secondary antibodies (Life Technologies) were incubated for 2 h at
RT diluted 1:200. All antibodies were diluted in PBS with 2.5%
donkey serum and 0.2% Triton-X. All wash steps were performed
using PBS 0.05% Tween-20. Sections were mounted with Prolong
Gold anti-fade media containing DAPI (Life Technologies).
Fluorescence images were acquired using an Olympus IX71
inverted microscope fitted with a high sensitivity CCD camera
(Cascade 512B, Photmetrics) and Metamorph image acquisition
software (Molecular Devices). Excitation filters for DAPI, green
and red fluorescence were, 350 nm, 480 nm and 545 nm
respectively. Emission filters were 460 nm, 525 nm and 600 nm.
Statistical analysis
All data are shown 6 standard error of mean and statistical
analysis was performed using single factor ANOVA and two-tailed
unpaired Student’s t-Test.
Table 1. Primer Sequences.
TargetForward Primer 59-39 Reverse Primer 39-59
Opn4L GCTACCGCTCTACCCACC CTACAGATGTCTGAGAGTCAC
Opn4S GCTACCGCTCTACCCACC CTACATCCCGAGATCCAGACT
Rho TGTTCCTGCTCATCGTGCTGG GGAAGTTGCTCATCGGCTTGC
MWS ATGGTGGTGGTGATGGTCTTCG TGTCTTGGAGGTGCTGGAAAGTTC
TH TGCTGTTCTCAACCTGCTCTTCTCC GGGTCTCTAAGTGGTGGATTTTGGC
Per-2 GGGGTGAGATTCGTCATTGAACTTG AGGACATTGGCACACTGGAAAGAG
c-fos ATCGGCAGAAGGGGAAAGTAG GCAACGCAGACTTCTCATCTTCAAG
GAPDH TGCACCACCAACTGCTTAG GATGCAGGGATGATGTTC
ARBP CGACCTGGAAGTCCAACTAC ATCTGCTGCATCTGCTTG
PSMB2 AAATGCGGAATGGATATGAAT GAAGACAGTCAGCCAGGTT
doi:10.1371/journal.pone.0034531.t001
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Expression of Opn4L and Opn4S mRNA during postnatal
development
To investigate the developmental expression profiles of Opn4L
and Opn4S we performed quantitative PCR using whole retina
samples isolated at P0, P5, P14 and P30 (n=6 per time point, all
tissue collected at ZT8). PCR analysis showed a different
expression profile for Opn4L and Opn4S transcripts during
postnatal retinal development. Following normalisation to the
expression of three housekeeping genes (Gapdh, Arbp, Pmsb2) levels
of Opn4S remained relatively consistent across the developmental
time points investigated, with a modest reduction in levels
observed over time (ANOVA not significant, F(3,19)=1.7,
P=0.20) (Figure 1A). In contrast normalised levels of Opn4L
expression were low at P0 and P5 but showed a significant increase
in expression (,2.5 fold) at P14 and P30 (F(3, 19)=10.0, P=0.004,
post hoc t-test, p=0.006 and p=4.1E-6 respectively) (Figure 1B).
A direct comparison between Opn4S and Opn4L expression levels
again showed a different profile of expression during postnatal
development with a significant change in the ratio of Opn4S and
Opn4L observed at P14 and P30 compared to earlier time points
(Figure 1C) (F(3,20)=14.1, P=0.0001, p=0.002 and p=0.002).
Consistent with the known timeline for the maturation of
functional rod and cone photoreceptors [24], normalised levels
of rhodopsin mRNA (F(3,19)=14.4 , P=0.0001, p=0.002 and
p=0.001) and middle wave sensitive (MWS) cone opsin mRNA
(F(3,19)=33.5, P=0.0001, p=3.2E-7 and p=0.0002) both showed
a marked increase at P14 and P30 compared to P5 (Figure 1D and
E). In addition levels of tyrosine hydroxylase mRNA (a marker of
dopaminergic cells) also showed a significant increase at P14 and
P30 time points (F(3,17)=11.4, P=0.0002, p=0.007 and
p=0.0005) (Figure 1F). Neither Opn4L, Opn4S nor TH showed
a significant increase between P0 and P5, but significant increases
were detected for rhodopsin (p=0.001) and MWS cone opsin
(p=0.02).
Expression and localisation of Opn4L and Opn4S protein
during postnatal development
Because of the significant changes in Opn4L mRNA observed
between P5 and P14 additional time points were included for
protein analysis. Immuno-staining of retinal sections from P0, P3,
P5, P10, P14 and P30 retina (n=3 retina per time point) with
Opn4S and Opn4L isoform-specific antibodies again showed a
differential pattern of expression for Opn4S and Opn4L during
postnatal retinal development. Opn4S was detected at all time
points investigated, with levels of Opn4S staining increasing
steadily over time from P0–P10. By contrast Opn4L could not be
detected at P0 and was detected only weakly in the early postnatal
retina with a clear up-regulation observed between P10 and P14
(Figure 2 and Figure 3). Based on our observations this differing
pattern of expression would seem to correlate with the maturation
of M1 and M2 type pRGCs. A detailed description of our
observations is given below and is summarised in Figure 4.
Opn4S expression was detected at P0, although levels of staining
were low, with only a small number Opn4S expressing cells
detected (Figure 4). The modest level of dendrite labelling and the
lack of stratification observed at this time point prevent classifica-
tion of these cells as either M1 or M2 type pRGCs. Despite
repeated efforts, Opn4L could not be detected at P0 (Figure 2A and
Figure 1. Expression of Opn4L and Opn4S mRNA during postnatal development. qPCR analysis showing the differential expression of
Opn4S (A) and Opn4L (B) mRNA during postnatal development of the retina, highlighted by the changing ratio of Opn4L/Opn4S mRNA (C).
Developmental profiles for rhodopsin (D), middle wave sensitive (MWS) cone opsin (E) and tyrosine hydroxylase (TH) are shown to indicate the
timeline for the development of the classical visual system. All expression data is shown normalised to the expression of three housekeeping genes
(Gapdh, Pmsb2, Arbp). Statistical results are shown for comparisons to data at P5. *=p,0.01, **=p,0.001, ***=p,0.0001. For Opn4L, Opn4S and
TH no significant differences were observed between P0 and P5, but significant increases were detected for rhodopsin (p=0.001) and MWS (p=0.02)
when comparing these time points.
doi:10.1371/journal.pone.0034531.g001
Developmental Expression of Melanopsin Isoforms
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e34531Figure 3A). By P3 the intensity of Opn4S labelling is increased in
individual pRGCs and allows the detection of a significantly
increased number of Opn4S positive cells (F(5, 151)=10.6,
P,0.0001, post hoc t-test, p=1.2E-8). Extensive networks of
dendritic processes are now visible, and are typically observed in all
sublamina of the developing IPL (Figure 2B and Figure 3B). Low
Figure 2. Expression of Opn4L and Opn4S protein during postnatal development. Immunohistochemistry images showing the expression
of Opn4L (red) and Opn4S (green) throughout postnatal retinal development. Note the changing ratio of Opn4L and Opn4S staining from P0 to P30.
Opn4S is detected at all time points, with levels of expression increasing from P0 to P3 but then rising only gradually until P10, whereby the majority
of Opn4S positive cells clearly resemble M1 type pRGCs. Opn4L is not detected at P0, and only very weakly at P3 and P5 within cells that also express
Opn4S (presumably M1 type pRGCs). Levels of Opn4L are slightly increased at P10 compared to P5, but are greatly increased at P14, with this rise
coinciding with the widespread detection of cells resembling M2 type pRGCs that express only Opn4L. For all images DAPI nuclear counterstain is
shown in blue. Merged images are show in right hand panels. ON and OFF correspond to the ON and OFF sublamina of the inner plexiform layer. M1
and M2 indicate cells classified as M1 and M2 type pRGCs. Arrows on images at P3 and P5 correspond to weakly Opn4L positive cells that can only be
classified based on visualisation of Opn4S expression. Levels of brightness and contrast enhancement have been increased for P0–P5 Opn4L images
to confirm the lack of detectable staining above background. Scale bar for all images=50 mm.
doi:10.1371/journal.pone.0034531.g002
Developmental Expression of Melanopsin Isoforms
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34531levels of Opn4L labelling were also observed at P3, although in all
cases expression of Opn4L was detected only in cells in which
Opn4S was also detected (Figure 2B and Figure 3B). Even at this
early time point a number of cells (38.2%, 66 of 173 melanopsin
positive cells) could be provisionally identified as early M1 type cells
with major process terminating almost exclusivelyin the developing
OFF layer of the IPL (Figure 2B and Figure 3B). By P5, levels of
both Opn4S and Opn4L staining were moderately increased
compared to P3, with a small further increase in the number of cells
detected (p=0.03). However again all melanopsin cells detected
Figure 3. Differential expression and of Opn4L and Opn4S during development correlates with the maturation of M1 and M2 type
pRGCs. Immunohistochemistry images showing the expression of Opn4L (red) and Opn4S (green) throughout postnatal retinal development,
highlighting the variety of cell types detected at each time point. Note that Opn4L and Opn4S positive cells resembling M1 type pRGCs can be
preliminarily identified as early as P3 and clearly be P5, whereas cells resembling M2 type pRGCs are detected only very weakly at P10 and not reliably
detected until P14, following a large increase in levels of Opn4L staining. For all images DAPI nuclear counterstain is show in blue. ON and OFF
correspond to the ON and OFF sublamina of the inner plexiform layer. M1=M1 type pRGCs, M2=M2 type pRGCs, dM1=displaced M1 type pRGC,
M3=M3 type pRGC, but is also used to label cells that are multi stratified during early development, ND=not defined, for cells that could not be
classified based on morphology alone. Scale bar for all images=50 mm.
doi:10.1371/journal.pone.0034531.g003
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remaining markedly higher than that of Opn4L. In general, the
level of cellular process appear somewhat refined by P5 compared
to P3, and although a notable proportion of pRGCs identified at P5
(Opn4S and Opn4L positive) remained multi-stratified (14.2%, 27
of 190 cells) or were otherwise unidentifiable as either M1 or M2
type cells, a large proportion of cells had morphologies clearly
resembling early M1 type cells (51.1%, 97 of 190 cells) (Figure 2C
and Figure 3C). Opn4S negative Opn4L positive cells, or cells
otherwise resembling M2 type cells were not identified at P5 using
these antibodies. By P10, levels of Opn4S and Opn4L labelling
were again increased in individual cells. Cells with morphologies
typical of mature M1 type cells were clearly identifiable. These cells
represented the vast majority of cells detected at this time point
(59.5%, 197 of 331 cells) and in all cases were positive for both
Opn4S and Opn4L (Figure 2D and Figure 3D). A small percentage
of multi-stratified or bistratified cells, expressing both Opn4S and
Opn4L, were still detected at P10 although these were rarer than at
P5 (7.9% and 14.2% respectively). In addition, at P10 cells
expressing only Opn4L and resembling M2 type cells could also be
identified. However, these cells were weakly labelled (barely
detected above background) and rarely detected, representing
10.9% (36 of 331 cells) of all melanopsin positive cells identified at
this time point (Figure 3D). At P14, cells with morphologies similar
to both mature M1 and M2 type cells were clearly evident.
Expression of both Opn4S and Opn4L was again detected in all
cells resembling M1 type cells, with levels of melanopsin staining
not noticeably increased above that seen at P10 (Figure 2E and
Figure 3E). However, in contrast to P10, at P14 cells with
morphologies resembling M2 type pRGCs were strongly labelled
and easily identifiable (Figure 2E and Figure 3E). These cells
express Opn4L alone, and represented 48.8% (258 of 529 cells) of
all melanopsin positive cells detected, with the total number of
Opn4L only cells detected now significantly increased compared to
P10 (F(5, 151)=59.2, P,0.0001, post hoc t-test, p=1.2E-15). The
dendritic processes of these Opn4L positive Opn4S negative M2
type cells were particularly pronounced at this time point, with a
wide, densely packed band of processes evident in the ON layer of
the IPL (Figure 2E and Figure 3E). This marked increase in Opn4L
staining, and the increase in the number of detectable M2 cells
coincides with the marked increase in expression of Opn4L mRNA
that occurs between P5 and P14 (Figure 1B). At P30, cells with
morphologies resembling mature M1 and M2 type cells were again
detected, with M1 type cells (40.2%, 178 of 442 cells) expressing
Figure 4. Summary of Opn4L and Opn4S expression profiles and timeline for maturation of M1 and M2 type pRGCs. A) Graph
showing the mean number of cells in which Opn4S and Opn4L or only Opn4L were detected per retinal section at each development time point.
Note the increasing numbers of Opn4S positive cells (also expressing Opn4L after P0) detected between P0 and P3 and also the increase in number of
Opn4L only cells detected at P14 compared to earlier time points. B) Graph showing the mean number of cells from each retinal section that could be
reliably classified as either M1, M2 or displaced M1 type pRGCs (dM1) based on morphology and stratification of dendrites. In all cases, cells classified
as M1 and M2 type pRGCs were positive for Opn4S and Opn4L or Opn4L only respectively. Changes in immuno-positive cells were assessed against
the previous time point in a stepwise manner. Significant differences are indicated, where the cell type is indicated by markers of the respective
colours. This data demonstrates significant increases in Opn4S expression at P0–P5 and Opn4L at P5–14. Corresponding increases in the number of
cells identified as M1 and M2 cells were observed at P0–P5, and P5–P14 respectively. *=p,0.05, **=p,0.001, ***=p,1.0E-6. The overall correlation
between the number of cells expressing Opn4S and Opn4L and those that could be classified as M1 type pRGCs based on morphology was 0.91. All
cells expressing only Opn4L were classified as M2 type pRGCs. C) Summary of the classifications assigned to cells at each time point shown as a
percentage of the total number of cells identified. As shown, cells resembling M1 type pRGCs were the dominant cell type identified in the early
postnatal retina, with M2 type cells not detected reliably until P14. Number of sections examined was typically 25–30 per retina, from n=3–4 retina
per time point. Cells with dendrites located in multiple layers of the IPL or were clearly bistratified were classified as Multi / M3. Cells for which
dendrites could not be clearly identified were classified as undefined. Prior to P10, all cells classified as undefined expressed both Opn4S and Opn4L
(except at P0 where Opn4L could not be detected) and most likely represent early M1 type cells. In order to estimate the total number of cells that
went undetected at each time point using the Opn4L and Opn4S antibodies (levels of under-reporting), the mean number of cells identified per
retinal section using the isoform specific antibodies was compared to values observed from similar analysis of sections stained using the highly
sensitive UF006 antibody that recognises both Opn4L and Opn4S.
doi:10.1371/journal.pone.0034531.g004
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cells) expressing only Opn4L (Figure 2F and Figure 3F). For both
M1 and M2 type cells, levels of melanopsin expression within
individual pRGCs was broadly similar at P30 compared to that
observed at P14. However, the density and branching complexity
of dendrites observed for Opn4L expressing M2 cells appear
markedly reduced at P30 compared to P14, with processes typically
now stratifying in a narrow band of the ON layer of the IPL
(Figure 2F and Figure 3F). The number of pRGCs that remained
bistratified in P14 and P30 tissue was low (2–5% of all pRGCs).
These bistratified cells, resembling M3 type pRGCs, were typically
found to express both Opn4S and Opn4L. In addition to the
classical M1 and M2 type cells we also observed a significant
proportion of displaced melanopsin positive ganglion cells with
their cell bodies located in the inner nuclear layer. The number of
displaced pRGCs was relatively constant from P5 (8.9%) to P30
(7.5%) (Figure 4). Without exception all displaced pRGCs detected
with these antibodies were positive for both Opn4S and Opn4L
and had dendrites restricted to the OFF layer of the IPL, consistent
with these cells being displaced M1 type pRGCs (Figure 3C, 3E
and 3F).
Overall, the results of our ICC studies using the Opn4L and
Opn4S specific antibodies show a different profile of Opn4L and
Opn4S expression over time during development, and based on
our observations this differing pattern of expression would seem to
correlate with the maturation of M1 and M2 type pRGCs (where
maturation is defined as cells reaching adult levels of melanopsin
expression). Opn4S expression and cells resembling M1 type
pRGCs are observed early in postnatal development, whereas in
contrast the increase in Opn4L expression detected between P10
and P14 coincides with a marked increase in the detection of cells
resembling M2 type pRGCs. Based on our observations, M2 cells
cannot be detected until P10, and not reliably until P14 using the
Opn4L antibody. One possible explanation is that M2 type cells
are not present in the retina prior to this time and emerge later in
development. Another, more likely explanation is that these cells
are present prior to this time, but the lower levels of melanopsin
expressed prevents detection by the Opn4L antibody. To address
this suggestion, localisation of melanopsin protein in the
developing retina was also performed using a highly sensitive
melanopsin antibody raised against the N-terminal region of
mouse melanopsin common to both Opn4L and Opn4S isoforms
(UF006 antibody). Labelling with the UF006 antibody was notably
more sensitive and intense compared to that observed for Opn4L
and Opn4S antibodies and allowed for more accurate visualisation
of cellular processes and improved detection of melanopsin
positive cells. This was particularly evident in P0–P5 retina
samples in which increased numbers of melanopsin expressing
cells were detected compared to that seen with the isoform specific
antibodies (Figure S2 and Figure S3). Estimates of the percentage
of melanopsin expressing cells detected using the isoform specific
antibodies at each time point is shown in Figure 4C. In agreement
with the results obtained with the Opn4S and Opn4L antibodies,
staining of retina sections and whole retina flatmounts with the
UF006 antibody again suggests a different timeline for the
maturation of M1 and M2 type pRGCs (Figure S2 and Figure S3).
Due to the increased sensitivity of the UF006 antibody, Opn4S
negative cells resembling early M2 type cells could be identified as
early as P3, although levels of staining were typically low
(Figure 5A). At this time point M2 cells have dense dendritic
fields that occupy a much broader area of the ON layer of the IPL
than that observed at P30 (Figure 5B). In comparison, the
morphology ad stratification of M1 cells at P3 are much more
similar to that observed in adult tissue (Fig. 5A and 5B). Due to the
weaker Opn4S (and Opn4L) antibody staining, and the low
number of Opn4S positive cells that can be detected in the P0
retina, the vast majority of cells detected at P0 were positive only
for UF006 (and not Opn4S or Opn4L). It was therefore not
possible to accurately determine the isoforms of melanopsin
expressed in the majority of pRGCs at P0.
Daily rhythm in Opn4L and Opn4S mRNA expression
To investigate the potential effect of daily rhythms in
melanopsin expression we examined the profile of both Opn4L
Figure 5. Differential expression of Opn4S is observed early in postnatal development in cells resembling M1 and M2 type pRGCs.
A) Double labelling with UF006 (red) and Opn4S (green) antibodies showing the differential expression of Opn4S in M1 and M2 type pRGC subtypes
as early as P3. B) Double labelling with Opn4L (red) and Opn4S (green) antibodies at P30 showing the morphology and pattern of melanopsin
expression in M1 and M2 type pRGCs of the adult retina. Note the similarities in morphology and levels of staining for M1 type pRGCs observed at P3
and P30, compared to the changes in morphology and staining that are observed for M2 type cells between these time points. For all images DAPI
nuclear counterstain is show in blue. Merged images are show in right hand panels. Scale bar for all images=50 mm.
doi:10.1371/journal.pone.0034531.g005
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day in adult mice (.P30) housed under 12:12 light dark cycles.
Results of qPCR analysis revealed no significant difference in
levels of either Opn4L mRNA (F(4,20)=2.13, P=0.13) or Opn4S
mRNA (F(4,20)=1.31, P=0.31) at any time point investigated
(Figure 6). Although not significant, the results of our qPCR
analysis do suggest a subtle trend for both Opn4L and Opn4S. The
rhythms of expression of both Opn4S and Opn4L, if present, would
appear to be synchronised, with no significant change in the ratio
of Opn4S:Opn4L detected at any time point investigated
(F(4,20)=0.13, P=0.97). Rhythmic patterns of expression were
detected for both Per2 mRNA (F(4,20)=2.60, P=0.082, p=0.0506)
and c-fos mRNA (F(4,20)=5.86, P=0.006, p=0.007) in these
samples, consistent with previous studies [25,26]. However despite
the obvious trend for Per2 mRNA expression we failed to observe
any significant differences for this data based on ANOVA analysis,
although post-hoc t-Test analysis does suggest a significant
difference between ZT13 and ZT18 (p=0.0506).
Discussion
The broad aims of this study were to determine the expression
of the recently identified Opn4 isoforms, Opn4L and Opn4S, during
postnatal retinal development. The results described here indicate
that Opn4L and Opn4S are differentially expressed during the
development of the mouse retina, and that the differential
expression of these melanopsin isoforms may be linked to the
functional maturation of M1 and M2 type pRGCs.
Opn4L and Opn4S are differentially expressed
throughout development
Levels of Opn4S mRNA expression were relatively constant
throughout development. By contrast levels of Opn4L mRNA
were low at birth and showed a significant (,2.5 fold) up-
regulation at P14 and P30 compared to earlier time points. In all
likelihood the absolute levels of both Opn4S and Opn4L
transcripts (i.e. total number of copies) are increased over time,
yet this increase is masked by the process of normalising target
gene expression to the levels of housekeeping gene expression,
where the increasing number of cells in the early postnatal retina
[27] will result in a dilution of melanopsin mRNA as a
percentage of the total mRNA pool. However, it is clear that
the changes in expression of Opn4L are more marked than those
of Opn4S, an observation confirmed by the changing ratio of
Opn4S/Opn4L detected at P14 and P30 compared to earlier time
points. Given the similarities in the amplification efficiencies for
the Opn4L and Opn4S primers used in this study [20] it would
seem that despite the increase in Opn4L expression at P14, Opn4S
remains the dominant transcript expressed in the retina
throughout the stages of postnatal development. Analysis of
Opn4S and Opn4L protein expression confirmed the results of
our PCR studies, and again demonstrated a differential
expression of these isoforms during postnatal development.
Opn4S protein was detected at all time points with a sharp rise
detected between P0 and P3, followed by a more gradual
increase over time until P10 where adult levels were observed. By
contrast, levels of Opn4L were low in the early retina and
showed a large up-regulation between P10 and P14.
Differential expression of Opn4L and Opn4S in
development correlates with the developmental
maturation of M1 and M2 type pRGCs
Consistent with our previous findings [20], we report a
differential pattern of expression for Opn4L and Opn4S within
subtypes of pRGCs in the adult retina. At P14 and P30, where
pRGC subtypes can be easily classified based on stratification of
their dendrites in the ON and OFF layers of the IPL, cells
identified as M1 type pRGCs were found to express both Opn4S
and Opn4L whereas only Opn4L could be detected in M2 type
pRGCs. Our current results now demonstrate a differential
pattern of expression for both Opn4S and Opn4L during postnatal
retinal development and suggest that this difference in profile of
expression may be linked to the differential maturation of M1 and
M2 type pRGCs. Based on our observations, M1 cells would seem
to mature first, with Opn4S detected at P0, and Opn4S and
Opn4L expressing cells with morphologies resembling M1 cells
provisionally identified as early as P3, and more clearly by P5, with
mature M1 type morphology clearly evident by P10. By contrast,
Opn4L positive M2 type cells with processes confined to the ON
layer of the IPL could not be detected at P0, P3 or P5 using the
Opn4L antibody, and were only rarely detected at P10. However,
by P14 Opn4L positive M2 cells are strongly labelled and
represent around 50% of all melanopsin positive cells identified.
Overall, the increase in Opn4L mRNA expression observed at P14
coincides with a large increase in the overall levels of Opn4L
protein expression and an increase in the number of M2 type
pRGCs that can be detected. We suggest that the increase in
photopigment expression that occurs in M2 type pRGCs may
correlate with a functional maturation of these cells, most likely
resulting in an increase in endogenous photosensitivity and
function. This is in contrast to M1 type cells that have detectable
levels of melanopsin expression from birth, show a rapid increase
in levels of expression between P0 and P3, and reach adult levels of
melanopsin expression earlier, between P5 and P10. Based on
these data, Opn4S is the dominant photopigment present at birth
and M1 type pRGCs would appear to be the dominant cell type
during early postnatal development, and are likely to be
responsible for the earliest light detection events that occur in
the mammalian retina.
It is possible that some of the cells classified as M2 type pRGCs
in this study may correspond to the recently identified M4 and M5
type pRGCs that also have processes located in the ON layer of
the IPL [8]. We think this unlikely, however, as levels of
melanopsin expression are reportedly very low in these cells and
they are not easily identified with the UF006 antibody but instead
are visualised only via detection of a fluorescent reporter in a
transgenic mouse line [8,10]. It is therefore unlikely that we would
detect these cells using the less sensitive Opn4L or Opn4S
antibodies.
Limitations in the sensitivity of immunohistochemistry prevent
us from determining whether the differential expression of Opn4S
and Opn4L occurs in cells of the P0 retina, and as such we are
unable to determine whether or not early pRGCs are predisposed
to forming M1 and M2 type cells prior to birth or whether these
cells differentiate postnatally from a common ‘melanopsin pre-
cursor’ cell. However, our results from double labelling with
UF006 and Opn4S antibodies suggests that differential expression
of Opn4S is present in pRGCs as early as P3, and as such it would
seem that cellular specialisation of pRGCs occurs early, and before
the process of stratification is completed.
In general the findings of our expression studies are consistent
with previous reports. Levels of melanopsin are known to be
relatively low at birth, and show a marked increase during the first
few days of postnatal development [4,17,28,29], resulting in a
significant increase in the photosensitivity of individual pRGCs
[4,12,28]. We would suggest that these early changes in
melanopsin expression are consistent with the increased levels of
Opn4S expression observed between P0 and P3 in our study and
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pRGCs. A further increase in sensitivity of pRGC responses is
observed around P11, driven largely by the emergence of
functional rod and cone photoreceptors [12]. It is currently
unclear whether or not there is also an increase in the levels of
intrinsic photosensitivity in M2 type pRGCs around this time
point, as would be expected from our data.
Why do M1 and M2 type pRGCs mature at different times
during development – a functional link between M2 type
cells and the classical visual system?
The reason why M1 and M2 pRGC subtypes mature at
different times during development is not clear. It is interesting to
note that the time frame for the up-regulation of Opn4L mRNA
Figure 6. Daily rhythm of Opn4L and Opn4S mRNA expression in the adult retina. qPCR analysis showing the levels of Opn4S (A) and Opn4L
(B) mRNA expression detected at different ZT time points from adult mice (P30–60) housed under 12:12 light dark cycles. ZT0=light on, ZT12=lights
off. C) Graph showing the ratio of Opn4S:Opn4L mRNA detected at different ZT time points. Note that data is triple plotted to highlight the rhythmic
trend. Periods of light and dark are indicated by shaded regions. D) Comparison of normalised daily rhythms for Opn4L and Opn4S. E) Levels of Per2
and F) Levels of c-fos mRNA expression detected at different ZT time points. All data is shown normalised to the expression of three housekeeping
genes (Gapdh, Pmsb2, Arbp). Statistical significance is shown for post-hoc t-tests for comparisons to ZT23. *=p=0.05, **=p,0.01.
doi:10.1371/journal.pone.0034531.g006
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occurs at a similar time to the up-regulation of rhodopsin, MWS
cone opsin and tyrosine hydroxylase mRNA and coincides with
the maturation of the classical visual system. In the adult retina
pRGCs are known to receive irradiance information from rod and
cone photoreceptors via synapses with bipolar and amacrine cells
and act as the principle conduit for passing rod and cone driven
information to brain areas involved in non-image forming
responses to light [30,31,32,33]. However, rod and cone
photoreceptors are not functional at birth but develop postnatally,
and do not become fully functional until P10–12 [34,35] with eye
opening typically observed around P13–14. Consistent with this
timeline, pRGCs begin to receive rod cone driven light signals at
around P11, resulting in significant changes in the cellular
responses of individual pRGCs [12]. From this it is clear that
the melanopsin system, although active from birth cannot become
fully mature until the classical rod and cone photoreceptors have
emerged and functional connections are made between melanop-
sin cells and the outer retina. There is now emerging evidence that
the function of M2 type cells may be more dependent on rod and
cone input than are M1 type cells. M2 type cells express much
lower levels of melanopsin protein and are less endogenously
photosensitive than M1 type cells, eliciting only small photocur-
rents in response to light stimulation in the absences of rod cone
driven input [8,14,36]. In addition, recent studies have also shown
that inputs from cone ON bipolar cells generate large depolarising
currents in M2 type cells, but only small responses in M1 type cells
[15]. Collectively these data suggest that the rod and cone pathway
exerts more influence on the functioning of M2 cells than M1 cells.
The photoresponses of M2 type cells are driven primarily by
excitatory inputs from the ON pathway with relatively little
contribution from melanopsin phototransduction, whereas mela-
nopsin function is almost entirely responsible for the generation of
photoresponses in M1 type cells [15]. Based on these observations,
it seems possible that the development or maturation of M2 type
pRGCs may be timed to more closely coincide with the
maturation of the classical visual system.
Daily rhythms in melanopsin expression
A number of studies have indicated that light exposure, or
exposure to light dark cycles, can influence levels of melanopsin
expression, potentially via the involvement of dopaminergic
amacrine cells [37,38,39,40,41]. It is therefore possible that daily
rhythms in Opn4L and Opn4S expression may contribute to the
different profiles of expression that we observe throughout
development. For example, Gonzalez-Menendez et al. [39] have
reported a daily rhythm in the number of melanopsin expressing
cells that can be detected via immunostaining in mice housed
under 12:12 light dark cycles. These results suggest a significant
decrease in the number of M1 cells detected between ZT23 and
ZT3 at the transition from dark to light, and a more subtle
increase in the number of M2 cells detected from ZT18 to ZT23.
This rhythm of melanopsin protein expression is absent under
conditions of constant darkness, suggesting a light driven effect
rather than an intrinsic circadian rhythm of melanopsin expression
in the adult retina [39]. Despite these previous reports, we could
not detect a significant daily rhythm in expression of either Opn4L
or Opn4S mRNA in adult mice housed under identical conditions
to those reported previously by Gonzalez-Menendez et al. [39].
Our data did however suggest a trend, and it is possible that a
higher number of replicate samples may have allowed detection of
a subtle rhythm. However, based on our results, should daily
rhythms in expression of Opn4L and Opn4S exist in the adult
retina it would seem that they are synchronised, with no evidence
of a daily variation in the ratio of Opn4S and Opn4L mRNA
detected. It is however possible that the process of analysing levels
of Opn4L and Opn4S mRNA from the whole retina has masked
subtle rhythms that may exist within the specific subsets of pRGCs.
From our data, it is clear that the magnitude of daily changes
detected for Opn4L and Opn4S mRNA in the adult retina are
relatively small. Should daily rhythms of similar magnitude exist
during development, it is unlikely that changes in the phase of
these rhythms could explain the marked changes in Opn4L
expression, and detection of M2 cells that we observe between P10
and P14. Dopamine is known to be light regulated in the retina
[42,43], and dopaminergic amacrine cells (DACs) have been
implicated in the regulation of melanopsin expression [40,41].
Given the close interactions of DACs and M1 type pRGCs [32] it
would seem that dopamine exerts influence primarily on M1 type
cells, a conclusion supported by recent findings [41]. However,
given the lack of functional rods, cones and dopamine amacrine
cells, we could realistically expect light dark cycles to exert less
influence on melanopsin expression in the early postnatal retina.
In support of this conclusion, it has been shown that light exposure
exerts no effect on the increased levels of melanopsin expression
that occur in the first 24 hours after birth [29]. Daily variations in
melanopsin expression have been reported for M1 cells as early as
P5, although rhythms of expression are seemingly absent from M2
cells at this time point [39]. Based on these reports, if daily
rhythms of expression are influencing the results of this study we
could reasonably expect larger variations in the expression of
Opn4S compared to Opn4L. However, in comparison to the
significant changes we detect for Opn4L, levels of Opn4S show no
such significant changes in expression between any developmental
time points investigated. Overall, it would seem there is little
compelling evidence for a robust daily rhythm in melanopsin
expression within M2 cells in either the adult or postnatal retina
[39]. Given these observations, it would seem unlikely that daily
variations in melanopsin expression can explain the different
profiles of Opn4L and Opn4S expression that we detect during
development, or explain the dramatic increase in detection of
Opn4L and M2 type pRGCs between P10 and P14. Furthermore,
daily variations in melanopsin expression would not explain the
clear difference in timeline for the morphological maturation of
the pRGC subtypes that we observe. As such, we believe that a
differential maturation of M1 and M2 type pRGCs best explains
the differential profile of Opn4L and Opn4S expression detected
in this study.
In support of our general conclusions regarding the differential
maturation of M1 and M2 type pRGCs, McNeill et al. [17] have
recently reported that different populations of pRGCs are born at
different times during prenatal development, and also that
different pRGC subtypes innervate their specific brain targets at
different time points during postnatal development [17]. These
data again suggest that the neural circuitry associated with the
different melanopsin systems do indeed mature at different rates
during postnatal development. It is possible that the up regulation
of melanopsin expression within specific subsets of pRGCs may be
a direct result of these cells establishing functional connections
with their respective recipient brain targets, or the onset of
functional activity in these target structures. Future studies will be
required to investigate these possibilities and determine that factors
that regulate expression of the different melanopsin isoforms and
the postnatal development of specific pRGC subtypes.
Summary
In summary, the results of the present study demonstrate that
Opn4L and Opn4S are differentially expressed during postnatal
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a model whereby there are two distinct phases of increased
melanopsin expression during postnatal development, an initial
increase between P0 and P3 driven primarily by an increase in
Opn4S expression, and a second increase that occurs between P10
and P14 driven by changes in Opn4L expression. Based on our
observations these two phases of increased melanopsin expression
would seem to correlate with the functional maturation of M1 and
M2 type pRGCs. We suggest that the specific functions associated
with M1 and M2 type pRGCs will mature at different times during
postnatal development.
Supporting Information
Figure S1 N-terminal melanopsin antibody UF006 rec-
ognises both Opn4L and Opn4S. Representative images
showing positive staining of both Opn4L and Opn4S transfected
Neuro-2A cells following incubation with the UF006 N-terminal
melanopsin antibody. Transient transfection and antibody staining
of Neuro-2A cell cultures was performed as described previously
[20].
(TIF)
Figure S2 UF006 flatmount staining throughout postna-
tal development. Representative images collected from whole
mount retina stained with the N-terminal melanopsin antibody
(UF006). Note the initial increase in melanopsin staining observed
between P0 and P3 and also the increase in weakly stained M2
type pRGCs observed at P14 compared to earlier time points.
Based on cell counts from whole flat mounted retina, we detected
1600–1800 pRGCs per adult retina (P30), comprising approxi-
mately 45% M1 type cells and 55% M2 type pRGCs, values that
are consistent with previous estimates of total numbers of
melanopsin cells in the adult mouse retina [10]. M1=M1 type
pRGCs, M2=M2 type pRGCs, dM1=displaced M1 type pRGC,
M3=M3 type pRGC, but is also used to label cells that are multi
stratified during early development, ND=not defined, for cells
that could not be classified based on morphology alone. For
staining of whole retina flatmounts, whole eyes were collected and
fixed as described for retinal sections. Retinae were then dissected
and cryoprotected in 30% sucrose prior to freeze thaw cycles (62)
with liquid N2. Retina were then washed in PBS with 1% Triton-X
63 for 10 mins, blocked in 10% donkey serum with 1% Triton-X
for 1 h at RT, and incubated with UF006 (1:2500) for 72 h at 4uC,
and Alexa 555 secondary antibody (1:200) for 24 h at 4uC, both
diluted in PBS with 2% donkey serum and 1% Triton-X.
(TIF)
Figure S3 Melanopsin expression during postnatal
development. Representative images showing the pattern of
melanopsin expression throughout postnatal retinal development
as detected using the UF006 melanopsin antibody (recognises both
Opn4L and Opn4S). At P0 levels of melanopsin expression are
low, with the majority of pRGCs only weakly labelled and not
typically identifiable as either M1 or M2 type pRGCs based on
morphology alone. Levels of melanopsin expression are markedly
increased by P3, and cells with morphologies resembling M1 type
pRGCs are tentatively identified at this time point, and more
definitively by P5 at which point the intensity of staining was
similar to that seen in adult tissue. Cells with morphologies
resembling M2 type pRGCs were tentatively identified at P3 and
more easily by P5 but levels of staining was low (presumably too
low for detection with the Opn4L antibody). A marked increase in
the intensity of staining was observed for M2 type pRGCs by P14.
At P14 M2 type cells are strongly labelled and typically have
extensive dense networks of processes spanning a relatively broad
region of the ON sublamina of the IPL. By P30 the processes of
M2 type cells appear less pronounced and typically stratify in a
narrow band of the ON layer of the IPL, consistent with the results
of the isoform specific antibodies. DAPI nuclear counterstain is
show in blue. ON and OFF correspond to the ON and OFF
sublamina of the inner plexiform layer. M1=M1 type pRGCs,
M2=M2 type pRGCs, dM1=displaced M1 type pRGC,
M3=M3 type pRGC, but is also used to label cells that are
multi stratified during early development, ND=not defined, for
cells that could not be classified based on morphology alone. Scale
bar for all images=50 mm.
(TIF)
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